Archangels welcomes investment enquiries from companies that fit all of the following criteria:
MUST be both operationally based and registered in Scotland, UK.
The investment opportunity can cover a range from ‘proof of concept’ through expansion capital, including start-up, early stage or series A but must have high growth potential, including international sales potential.
Should have Intellectual Property (IP): defendable, disruptive technology and / or know-how, difficult to replicate.
Must be in a sector which qualifies under the Enterprise Investment Scheme.
Must be a technology or life science business with a B2B business model.
Seeking initial funding of £250k to £2m.
Our team review circa 200 investment enquiries per year. The following is a brief overview of our review process:
Submission reviewed and business assessed against our investment criteria to ensure alignment.
If investment criteria are met, details will be added to our New Deals list for discussion at the next New Deals Committee (NDC) meeting. Meetings are approximately fortnightly.
If the NDC is supportive of progressing, we will conduct detailed due diligence.
When due diligence is substantially complete, with no issues raised, the management team will be asked to present to the Archangels Board.
Following Board approval, pricing will be agreed and a term sheet issued.
On execution of the term sheet, a date will be set for the company to give one presentation to Archangel members. Can be in person or online.
Following the member presentation, the fundraising process begins. This involves the book building; where individual Archangel syndicate members confirm how much they will invest.
Archangels is always lead investor; negotiating legal documentation including the Investment Agreement and gathering of funds. If appropriate, we may also co-ordinate co-investment.
Submit an investment enquiry
Please submit details of your investment opportunity for our team to review.
You should include an overview of the company and details of any IP / USP, together with a summary outlining your funding requirements and how it will be used.
Our clear preference is to invest in companies which are not capital intensive and are capable of achieving scale and generating revenues without significant capex.